Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Molecular and Chemical Neuropathology|January 1, 1994
Long-term MPTP-treated monkeys are resistant to GM1 systemic therapyM E Emborg, J A ColomboExperimental Neurology|August 26, 1998
MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid doseM E Emborg-Knott, E F DominoCurrent Neurology and Neuroscience Reports|October 5, 2018
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant PhenotypesS L Sison, S C Vermilyea, M E Emborg, et al.Cell Transplantation|January 6, 2001
Technique for bilateral intracranial implantation of cells in monkeys using an automated delivery systemK S Bankiewicz, J Bringas, P Pivirotto, et al.The Journal of Comparative Neurology|November 20, 1998
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeysM E Emborg, S Y Ma, E J Mufson, et al.Brain Research|March 7, 1997
6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primatesS Jordan, J L Eberling, K S Bankiewicz, et al.Experimental Neurology|February 15, 2001
Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeysM E Emborg, P Shin, B Roitberg, et al.Neurobiology of Disease|June 13, 2006
Basal ganglia lesions after MPTP administration in rhesus monkeysM E Emborg, J Moirano, K T Schafernak, et al.Neurobiology of Disease|August 8, 2009
Response of aged parkinsonian monkeys to in vivo gene transfer of GDNFM E Emborg, J Moirano, J Raschke, et al.Science (New York, N.Y.)|October 29, 2000
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's diseaseJ H Kordower, M E Emborg, J Bloch, et al.Pageof 1